STOCK TITAN

[8-K] ScanTech AI Systems Inc. Common stock Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Copart Inc. (CPRT) has filed a Form 144 indicating the proposed sale of 24,088 common shares through Morgan Stanley Smith Barney on the NASDAQ around 15 July 2025. The shares were recently acquired on the same date via the cash exercise of stock options. Based on the filing’s stated outstanding share count of 966.9 million, the planned sale represents roughly 0.0025 % of total shares, with an aggregate market value of $1.14 million. No other sales by the same insider were reported in the past three months, and no additional material information—such as the seller’s identity or relationship to the issuer—was disclosed.

The notice is routine and does not, by itself, suggest any change in Copart’s fundamentals; rather, it provides procedural advance disclosure required when an insider intends to sell restricted or control securities under Rule 144.

Copart Inc. (CPRT) ha presentato un Modulo 144 indicando la proposta vendita di 24.088 azioni ordinarie tramite Morgan Stanley Smith Barney sul NASDAQ intorno al 15 luglio 2025. Le azioni sono state recentemente acquisite nella stessa data tramite il esercizio in contanti di opzioni azionarie. Basandosi sul numero totale di azioni in circolazione dichiarato nel deposito, pari a 966,9 milioni, la vendita pianificata rappresenta circa lo 0,0025% del totale delle azioni, con un valore di mercato aggregato di 1,14 milioni di dollari. Negli ultimi tre mesi non sono state segnalate altre vendite da parte dello stesso insider e non sono state divulgate ulteriori informazioni rilevanti, come l’identità del venditore o il suo rapporto con l’emittente.

La comunicazione è di routine e non suggerisce, di per sé, alcun cambiamento nei fondamentali di Copart; fornisce invece una comunicazione preventiva richiesta quando un insider intende vendere titoli soggetti a restrizioni o di controllo secondo la Regola 144.

Copart Inc. (CPRT) ha presentado un Formulario 144 indicando la venta propuesta de 24,088 acciones ordinarias a través de Morgan Stanley Smith Barney en NASDAQ alrededor del 15 de julio de 2025. Las acciones fueron adquiridas recientemente en la misma fecha mediante el ejercicio en efectivo de opciones sobre acciones. Según el número de acciones en circulación declarado en el formulario, que es de 966.9 millones, la venta planificada representa aproximadamente el 0.0025% del total de acciones, con un valor de mercado agregado de 1.14 millones de dólares. No se reportaron otras ventas por parte del mismo insider en los últimos tres meses, ni se divulgó información adicional importante, como la identidad del vendedor o su relación con el emisor.

El aviso es rutinario y por sí solo no sugiere ningún cambio en los fundamentos de Copart; más bien, proporciona una divulgación anticipada requerida cuando un insider planea vender valores restringidos o de control bajo la Regla 144.

Copart Inc.(CPRT)는 Morgan Stanley Smith Barney를 통해 NASDAQ에서 2025년 7월 15일경 24,088주 보통주 매각 예정임을 알리는 Form 144를 제출했습니다. 해당 주식은 같은 날 주식매수선택권 현금 행사를 통해 최근에 취득한 것입니다. 제출된 자료에 명시된 발행 주식 수는 9억 6,690만 주로, 이번 매각 예정 주식은 전체 주식의 약 0.0025%에 해당하며, 총 시장 가치는 114만 달러에 달합니다. 지난 3개월간 동일 내부자의 다른 매각 보고는 없었으며, 판매자 신원이나 발행사와의 관계 등 추가 중요한 정보도 공개되지 않았습니다.

이 공지는 일상적인 절차로, 단독으로 Copart의 기본적인 사항에 변화를 시사하지 않으며, 내부자가 Rule 144에 따라 제한 주식 또는 지배 주식을 매각하려 할 때 요구되는 사전 절차적 공시입니다.

Copart Inc. (CPRT) a déposé un Formulaire 144 indiquant la vente proposée de 24 088 actions ordinaires via Morgan Stanley Smith Barney sur le NASDAQ aux alentours du 15 juillet 2025. Ces actions ont été récemment acquises à la même date par le biais de l'exercice au comptant d’options sur actions. Sur la base du nombre d’actions en circulation déclaré dans le dépôt, qui s’élève à 966,9 millions, la vente prévue représente environ 0,0025 % du total des actions, avec une valeur marchande globale de 1,14 million de dollars. Aucune autre vente par le même initié n’a été signalée au cours des trois derniers mois, et aucune information supplémentaire importante — telle que l’identité du vendeur ou sa relation avec l’émetteur — n’a été divulguée.

L’avis est de routine et ne suggère pas, en soi, de changement dans les fondamentaux de Copart ; il constitue plutôt une divulgation préalable requise lorsqu’un initié prévoit de vendre des titres restreints ou de contrôle selon la Règle 144.

Copart Inc. (CPRT) hat ein Formular 144 eingereicht, das den geplanten Verkauf von 24.088 Stammaktien über Morgan Stanley Smith Barney an der NASDAQ um den 15. Juli 2025 anzeigt. Die Aktien wurden am selben Tag durch die Barausübung von Aktienoptionen erworben. Basierend auf der im Formular angegebenen ausstehenden Aktienzahl von 966,9 Millionen entspricht der geplante Verkauf etwa 0,0025 % der Gesamtaktien mit einem Gesamtmarktwert von 1,14 Millionen US-Dollar. In den letzten drei Monaten wurden keine weiteren Verkäufe desselben Insiders gemeldet, und es wurden keine zusätzlichen wesentlichen Informationen – wie die Identität des Verkäufers oder dessen Beziehung zum Emittenten – offengelegt.

Die Mitteilung ist routinemäßig und deutet für sich genommen nicht auf eine Veränderung der Fundamentaldaten von Copart hin; sie dient vielmehr der vorgeschriebenen vorläufigen Offenlegung, wenn ein Insider beabsichtigt, eingeschränkte oder Kontrollwerte gemäß Regel 144 zu verkaufen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small Rule 144 filing; 24k-share insider sale (<0.003 % o/s) worth $1.1 m—unlikely to move CPRT.

The filing signals a modest liquidity move by an insider, with no evidence of broader divestment trends (no prior 3-month sales). Importantly, the sale size is immaterial relative to Copart’s ~967 million shares outstanding and should not affect float or price dynamics. Because the options were exercised concurrently, the transaction appears to be a routine monetisation event rather than a strategic exit. Unless accompanied by additional insider selling or adverse disclosures, the market impact is expected to be negligible.

Copart Inc. (CPRT) ha presentato un Modulo 144 indicando la proposta vendita di 24.088 azioni ordinarie tramite Morgan Stanley Smith Barney sul NASDAQ intorno al 15 luglio 2025. Le azioni sono state recentemente acquisite nella stessa data tramite il esercizio in contanti di opzioni azionarie. Basandosi sul numero totale di azioni in circolazione dichiarato nel deposito, pari a 966,9 milioni, la vendita pianificata rappresenta circa lo 0,0025% del totale delle azioni, con un valore di mercato aggregato di 1,14 milioni di dollari. Negli ultimi tre mesi non sono state segnalate altre vendite da parte dello stesso insider e non sono state divulgate ulteriori informazioni rilevanti, come l’identità del venditore o il suo rapporto con l’emittente.

La comunicazione è di routine e non suggerisce, di per sé, alcun cambiamento nei fondamentali di Copart; fornisce invece una comunicazione preventiva richiesta quando un insider intende vendere titoli soggetti a restrizioni o di controllo secondo la Regola 144.

Copart Inc. (CPRT) ha presentado un Formulario 144 indicando la venta propuesta de 24,088 acciones ordinarias a través de Morgan Stanley Smith Barney en NASDAQ alrededor del 15 de julio de 2025. Las acciones fueron adquiridas recientemente en la misma fecha mediante el ejercicio en efectivo de opciones sobre acciones. Según el número de acciones en circulación declarado en el formulario, que es de 966.9 millones, la venta planificada representa aproximadamente el 0.0025% del total de acciones, con un valor de mercado agregado de 1.14 millones de dólares. No se reportaron otras ventas por parte del mismo insider en los últimos tres meses, ni se divulgó información adicional importante, como la identidad del vendedor o su relación con el emisor.

El aviso es rutinario y por sí solo no sugiere ningún cambio en los fundamentos de Copart; más bien, proporciona una divulgación anticipada requerida cuando un insider planea vender valores restringidos o de control bajo la Regla 144.

Copart Inc.(CPRT)는 Morgan Stanley Smith Barney를 통해 NASDAQ에서 2025년 7월 15일경 24,088주 보통주 매각 예정임을 알리는 Form 144를 제출했습니다. 해당 주식은 같은 날 주식매수선택권 현금 행사를 통해 최근에 취득한 것입니다. 제출된 자료에 명시된 발행 주식 수는 9억 6,690만 주로, 이번 매각 예정 주식은 전체 주식의 약 0.0025%에 해당하며, 총 시장 가치는 114만 달러에 달합니다. 지난 3개월간 동일 내부자의 다른 매각 보고는 없었으며, 판매자 신원이나 발행사와의 관계 등 추가 중요한 정보도 공개되지 않았습니다.

이 공지는 일상적인 절차로, 단독으로 Copart의 기본적인 사항에 변화를 시사하지 않으며, 내부자가 Rule 144에 따라 제한 주식 또는 지배 주식을 매각하려 할 때 요구되는 사전 절차적 공시입니다.

Copart Inc. (CPRT) a déposé un Formulaire 144 indiquant la vente proposée de 24 088 actions ordinaires via Morgan Stanley Smith Barney sur le NASDAQ aux alentours du 15 juillet 2025. Ces actions ont été récemment acquises à la même date par le biais de l'exercice au comptant d’options sur actions. Sur la base du nombre d’actions en circulation déclaré dans le dépôt, qui s’élève à 966,9 millions, la vente prévue représente environ 0,0025 % du total des actions, avec une valeur marchande globale de 1,14 million de dollars. Aucune autre vente par le même initié n’a été signalée au cours des trois derniers mois, et aucune information supplémentaire importante — telle que l’identité du vendeur ou sa relation avec l’émetteur — n’a été divulguée.

L’avis est de routine et ne suggère pas, en soi, de changement dans les fondamentaux de Copart ; il constitue plutôt une divulgation préalable requise lorsqu’un initié prévoit de vendre des titres restreints ou de contrôle selon la Règle 144.

Copart Inc. (CPRT) hat ein Formular 144 eingereicht, das den geplanten Verkauf von 24.088 Stammaktien über Morgan Stanley Smith Barney an der NASDAQ um den 15. Juli 2025 anzeigt. Die Aktien wurden am selben Tag durch die Barausübung von Aktienoptionen erworben. Basierend auf der im Formular angegebenen ausstehenden Aktienzahl von 966,9 Millionen entspricht der geplante Verkauf etwa 0,0025 % der Gesamtaktien mit einem Gesamtmarktwert von 1,14 Millionen US-Dollar. In den letzten drei Monaten wurden keine weiteren Verkäufe desselben Insiders gemeldet, und es wurden keine zusätzlichen wesentlichen Informationen – wie die Identität des Verkäufers oder dessen Beziehung zum Emittenten – offengelegt.

Die Mitteilung ist routinemäßig und deutet für sich genommen nicht auf eine Veränderung der Fundamentaldaten von Copart hin; sie dient vielmehr der vorgeschriebenen vorläufigen Offenlegung, wenn ein Insider beabsichtigt, eingeschränkte oder Kontrollwerte gemäß Regel 144 zu verkaufen.

false 0001994624 0001994624 2025-07-10 2025-07-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 10, 2025

 

ScanTech AI Systems Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-42463   93-3502562

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

  (I.R.S. Employer
Identification No.)

 

1735 Enterprise Drive

Buford, Georgia

  30518
(Address of principal executive offices)   (Zip Code)

 

+1 (470) 655-0886

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which registered
Common Stock, par value $0.0001 per share   STAI   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On July 10, 2025, ScanTech AI Systems Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”) for continued listing on The Nasdaq Global Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share, and, based upon the closing bid price of the Company’s common stock for the 30 consecutive business days for the period of May 23, 2025 to July 8, 2025, the Company no longer meets this requirement. The Notice has no immediate effect on the listing of the Company’s common stock on The Nasdaq Global Market.

 

The Notice indicated that the Company will be provided 180 calendar days, or until January 6, 2026, in which to regain compliance. If at any time during this 180 calendar day period the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of ten consecutive business days, the Nasdaq staff (the “Staff”) stated that it will provide the Company with a written confirmation of compliance and the matter will be closed. However, under Nasdaq Listing Rule 5810(c)(3)(A), the Staff may exercise its discretion to extend this ten day period as discussed in Rule 5810(c)(3)(H).

 

Alternatively, if the Company fails to regain compliance with the Bid Price Requirement prior to the expiration of the initial 180 calendar day period, the Company may be eligible for an additional time, provided that the Company (i) submits an application to transfer its listing to The Nasdaq Capital Market and pays the associated fee, (ii) meets the continued listing requirement for market value of publicly held shares and all other initial listing standards (except for the Bid Price Requirement), and (iii) provides written notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. In the event the Company does not regain compliance with the Bid Price Requirement prior to the expiration of the initial 180 calendar day period, and if the Staff concludes that the Company will not be able to cure the deficiency, or should the Company determine not to submit a transfer application or make the required representation, the Staff stated that it will provide the Company with notice that its securities will be subject to delisting. At that time, the Company may appeal the delisting determination to a Hearings Panel.

 

The Company intends to actively monitor the closing bid price of its common stock and is considering its options to regain compliance with the Bid Price Requirement. There can be no assurance that the Company will be able to regain compliance with the Bid Price Requirement.

 

Item 8.01. Other Events.

 

On July 15, 2025, the Company issued a press release announcing its receipt of the Notice from Nasdaq. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
99.1   Press Release, dated July 15, 2025.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 15, 2025 SCANTECH AI SYSTEMS INC.
   
  By: /s/ Dolan Falconer
  Name:   Dolan Falconer
  Title: Chief Executive Officer

 

 

 

 

FAQ

How many Copart (CPRT) shares are being sold under this Form 144?

The notice covers 24,088 common shares.

What is the aggregate market value of the planned Copart share sale?

The filing lists an aggregate market value of $1,135,267.44.

When is the approximate sale date for the Copart shares?

The shares may be sold on or about July 15, 2025.

What percentage of Copart’s outstanding shares does the sale represent?

Approximately 0.0025 % of the 966.9 million shares outstanding.

How were the shares acquired before the planned sale?

They were obtained through the exercise of stock options on July 15, 2025, paid in cash.

Which broker is handling the transaction?

Morgan Stanley Smith Barney LLC Executive Financial Services.
ScanTech AI Systems Inc.

NASDAQ:STAI

STAI Rankings

STAI Latest News

STAI Latest SEC Filings

STAI Stock Data

16.88M
33.97M
7.6%
34.51%
3.19%
Building Products & Equipment
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
NEW YORK